$BIO holders in @BioProtocol gain early access to vetted biotech projects. Unlike traditional systems, this decentralized model ensures fair entry points for the community. Science becomes open to all. 🌍
With $BIO, @BioProtocol creates continuous revenue streams via trading fees, liquidity pools, and milestone rewards. This ensures biotech projects are financially sustainable while delivering breakthroughs.
$BIO fuels AI-powered BioAgents 🤖 on @BioProtocol, accelerating data analysis, hypothesis testing, and research automation. The combination of DeSci and AI is building a faster, smarter scientific ecosystem.
Every trade in biotech tokens fuels @BioProtocol. Fees flow back into the treasury, liquidity grows, and $BIO demand rises. A sustainable model where financial activity directly funds science.
With @BioProtocol, biotech IP becomes liquid, accessible, and tradable. $BIO fuels this transformation, turning locked patents into community-owned assets that fund the next generation of discoveries.
Every $BIO staker has the chance to shape the future of human health. On @BioProtocol, you don’t just back projects—you govern them, ensuring science remains transparent, accountable, and aligned with community values.
With $BIO, @BioProtocol turns every backer into an active participant in biotech’s future. Stake, govern, and support early-stage research while benefiting from transparent, community-driven growth.
Forget gatekeepers. 🔑 @BioProtocol lets communities fund science directly with $BIO, ensuring fresh ideas don’t get lost in bureaucracy but instead move forward with collective support.
Every $BIO staked in @BioProtocol powers new biotech. Researchers get continuous funding, communities gain influence, and backers secure early allocations. Together, they shape the future of science.
$BIO holders get more than governance—they unlock the chance to back biotech projects from the very beginning through @BioProtocol. Transparent, inclusive, and built for collective progress.
🧑🔬 Distributed BioXP aligns researchers, patients & investors. By staking $BIO with @Bioprotocol, you earn points that fund science & give you governance power over biotech projects. Science is now owned by the community. #BioXP#DeSci
🤖 Automation in biotech? Meet BioAgents at @BioProtocol. $BIO powers AI agents that analyze data, generate hypotheses & accelerate discovery. Science, supercharged by decentralized automation. #AI#DeSci
@BioProtocol is building the new economy of science. 🔬 $BIO fuels governance, liquidity, funding & automation, transforming research into a transparent, sustainable, community-owned ecosystem of innovation.
.@Aubrai_ is coming, our first BioAgent launch.
What you need to know:
> Sale lasts 24 hours
> During this time, you’ll be able to pledge BioXP and commit $BIO to participate
> Your allocation will be determined at the end of the 24h period based on your pledged BioXP relative to the total pledged BioXP
> BioXP earned for yapping will go live in the front-end before the sale, and you’ll be able to pledge it along with XP earned from staking
> $AUBRAI will go live for open market trading almost immediately after the sale closes
⚠️ To be clear: the sale is not ‘first come first serve’ — so long as you pledge BioXP in the 24-hour window, you’ll be eligible for an allocation.
We’ll alert the community once the sale goes live.
Stay locked:
https://t.co/vbJXyUMMPc
@BioProtocol ensures funding doesn’t stop at launch. 📈 With $BIO, projects access ongoing liquidity pools, sustainable rewards & continuous support. Science shouldn’t be a one-time bet—it should be a long-term engine of innovation.
@BioProtocol ties rewards to results. 🎯 With $BIO, research projects unlock funding only when they deliver milestones. This ensures accountability, transparency & measurable progress—aligning researchers with communities and long-term outcomes.
Every $BIO holder is more than an investor—they’re a co-creator. With @BioProtocol, staking means governing, funding & accelerating projects. It’s science owned, guided & scaled by the people.
Utopia is not a static destination but a process.
It emerges when biology and technology converge so seamlessly that their presence fades into the background of everyday life.
Yet this trajectory is not self-propelling.
The translation of scientific insight into societal transformation depends on consistent funding to move fragile discoveries out of theory and into application.
Without capital, the arc of possibility bends back into silence.